Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.
Geopolitics, crude risk and the IT conundrum: Sridhar Sivaram on why investors may need to stay selective
Geopolitical tensions in West Asia are creating market uncertainty, impacting energy supplies and capital flows. While Indian equities have shown resilience, prolonged conflict could significantly